NCT04064073 - Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2019

Conditions

Healthy

Interventions

DRUG

DWP16001

Tablets, Oral, once daily single dose

DRUG

Metformin IR

Metformin IR 1000mg, Tablets, Oral, BID for 7 days

DRUG

DWP16001+Metformin IR

Tablets, Oral, once daily single dose DWP16001 Metformin IR 1000mg

Trial Locations (1)

Seoul National University Hospital, Seoul